Cargando…
miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is a common hepatic disease with an increasing prevalence but an unclear aetiology. This study aimed to investigate the functional implications of microRNA-122 (miR-122) in the pathogenesis of NAFLD and the possible molecular mechanisms. METHODS:...
Autores principales: | Long, Jun-Ke, Dai, Wen, Zheng, Ya-Wen, Zhao, Shui-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567918/ https://www.ncbi.nlm.nih.gov/pubmed/31195981 http://dx.doi.org/10.1186/s10020-019-0085-2 |
Ejemplares similares
-
Phloretin ameliorates hepatic steatosis through regulation of lipogenesis and Sirt1/AMPK signaling in obese mice
por: Liou, Chian-Jiun, et al.
Publicado: (2020) -
6-phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumor growth by inhibiting LKB1-AMPK signaling
por: Lin, Ruiting, et al.
Publicado: (2015) -
AMPK potentiation by LKB1 isoforms
por: Thibert, Chantal, et al.
Publicado: (2015) -
Pirfenidone Is an Agonistic Ligand for PPARα and Improves NASH by Activation of SIRT1/LKB1/pAMPK
por: Sandoval‐Rodriguez, Ana, et al.
Publicado: (2020) -
miR-122/SIRT1 axis regulates chondrocyte extracellular matrix degradation in osteoarthritis
por: Bai, Yinwei, et al.
Publicado: (2020)